Photoaffinity analog of the semisynthetic echinocandin LY303366: Identification of echinocandin targets in Candida albicans

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 5, 1998, Pages 1187-1194

  Radding, Jeffrey A ^a   Heidler, Steven A ^a   Turner, William W ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIDULAFUNGIN; BETA 1,3 GLUCAN; CILOFUNGIN; CYANOGEN BROMIDE; ECHINOCANDIN B DERIVATIVE;

AMINO ACID SEQUENCE; ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; DRUG POTENCY; DRUG PURIFICATION; DRUG TARGETING; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHOTOAFFINITY LABELING; PRIORITY JOURNAL; RADIOIODINATION;

EID: 0031981860     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.5.1187     Document Type: Article

References (49)

1. Altschul, S. F., W. Gish, W. Miller, E. W. Myers, and D. J. Lipman. 1990. Basic local alignment search tool. J. Mol. Biol. 215:403-410.
2. Awald, P., M. Zugel, C. Monks, D. Frost, and C. P. Selitrennikoff. 1993. Purification of 1,3-β-D-glucan synthase from Neurospora crassa by product entrapment. Exp. Mycol. 17:130-141.
3. Balkovec, J. M. 1994. Lipopeptide antifungal agents. Expert Opin. Invest. Drugs 3:65-82.
4. Castro, C., J. C. Ribas, M. H. Valdivieso, R. Varona, F. del Rey, and A. Duran. 1995. Papulacandin B resistance in budding and fission yeasts: isolation and characterization of PBR1, a gene involved in (1,3)-β-D-glucan synthesis in Saccharomyces cerevisiae. J. Bacteriol. 177:5732-5739.
5. Cleveland, D. W. 1983. Peptide mapping in one dimension by limited proteolysis of sodium dodecyl sulfate-solubilized proteins. Methods Enzymol. 96:222-229.
6. Como, J. A., and W. E. Dismukes. 1994. Oral azole drugs as systemic antifungal therapy. N. Engl. J. Med. 330:263-272.
7. Current, W. L., C. Boylan, and P. Raab. 1993. Presented at the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, La., 17 to 20 Oct. 1993.
8. Debono, M., W. W. Turner, L. LaGrandeur, F. J. Burkhardt, J. S. Nissen, K. K. Nichols, M. J. Rodriguez, M. J. Zweifel, D. J. Zeckner, R. S. Gordee, J. Tang, and T. R. J. Parr. 1995. Semisynthetic chemical modification of the antifungal lipopeptide echinocandin B (ECB): structure-activity studies of the lipophilic and geometric parameters of polyarylated analogs of ECB. J. Med. Chem. 38:3271-3281.
9. Devereux, J., P. Haeberli, and O. Smithies. 1984. A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Res. 12:387-395.
10. Difco Laboratories. 1984. Difco manual, 10th ed. Difco Laboratories, Detroit, Mich.
11. Dixon, C. K., and D. Ma. 1995. Characterization of ECB LY280949 resistant mutants in Saccharomyces cerevisiae. Yeast 11:S538.
12. Douglas, C. M., F. Foor, J. A. Marrinan, N. Morin, J. B. Nielsen, A. M. Dahl, P. Mazur, W. Baginsky, W. Li, M. El-Sherbeini, J. A. Clemas, S. M. Mandala, B. R. Frommer, and M. B. Kurtz. 1994. The Saccharomyces cerevisiae FKS1 (ETG1) gene encodes an integral membrane protein which is a subunit of 1,3-β-D-glucan synthase. Proc. Natl. Acad. Sci. USA 91:12907-12911.
13. Douglas, C. M., J. A. Marrinan, W. Li, and M. B. Kurtz. 1994. A Saccharomyces cerevisiae mutant with echinocandin-resistant 1,3-β-D-glucan synthase. J. Bacteriol. 176:5686-5696.
14. Drgnova, J., T. Drgon, K. Tanaka, R. Kollar, G.-C. Chen, R. A. Ford, C. S. M. Chan, Y. Takai, and E. Cabib. 1996. Rho1p, a yeast protein at the interface between cell polarization and morphogenesis. Science 272:277-281.
15. El-Sherbeini, M., and J. A. Clemas. 1995. Cloning and characterization of GNS1: a Saccharomyces cerevisiae gene involved in synthesis of 1,3-β-glucan in vitro. J. Bacteriol. 177:3227-3234.
16. Frost, D., K. Brandt, C. Estill, and R. Goldman. 1997. Partial purification of (1,3)-β-glucan synthase from Candida albicans. FEMS Microbiol. Lett. 146: 255-261.
17. Frost, D., R. R. Drake, and B. P. Wasserman. 1992. (1,3)-β-Glucan synthase from Saccharomyces cerevisiae: in vitro activation by β-lactoglobulin or Brij-35, and photoaffinity labeling of enriched microsomal fractions with 5-azido-UDP-Glc and 8-azido-GTP. Curr. Microbiol. 24:295-300.
18. Frost, D. J., K. Brandt, J. Capobianco, and R. Goldman. 1994. Characterization of (1,3)-β-glucan synthase in Candida albicans: microsomal assay from the yeast or mycelial morphological forms and a permeabilized whole-cell assay. Microbiology 140:2239-2246.
19. Gallis, H. A., R. H. Drew, and W. W. Pickard. 1990. Amphotericin B: 30 years of clinical experience. Rev. Infect. Dis. 12:308-329.
20. +-ATPase. Mol. Cell. Biol. 15:4103-4114.
21. Goff, D. A., S. L. Koletar, W. J. Buesching, J. Barnisham, and R. J. Fass. 1995. Isolation of fluconazole-resistant Candida albicans from human immunodeficiency virus-negative patients never treated with azoles. Clin. Infect. Dis. 20:77-83.
22. Gutmann, D. H., M. Boguski, D. Marchuk, M. Wigler, F. S. Collins, and R. Ballester. 1993. Analysis of the neurofibromatosis type 1 (NF1) GAP-related domain by site directed mutagenesis. Oncogene 8:761-769.
23. Inoue, S. B., N. Takewaki, T. Takasuka, T. Mio, M. Adachi, Y. Fujii, C. Miyamoto, M. Arisawa, Y. Furuichi, and T. Watanabe. 1995. Characterization and gene cloning of 1,3-β-D-glucan synthase from Saccharomyces cerevisiae. Eur. J. Biochem. 231:845-854.
24. Keller-Juslen, C., and M. Kuhn. August 1977. German patent 2,704,030.
25. Kelly, R., E. Register, M. Hsu, M. Kurtz, and J. Nielsen. 1996. Isolation of a gene involved in a 1,3-β-glucan synthesis in Aspergillus nidulans and purification of the corresponding protein. J. Bacteriol. 178:4381-4391.
26. Kurtz, M. B., G. Abruzzo, A. Flattery, K. Bartizal, J. A. Marrinan, W. Li, J. Milligan, K. Nollstadt, and C. M. Douglas. 1996. Characterization of echinocandin-resistant mutants of Candida albicans: genetic, biochemical, and virulence studies. Infect. Immun. 64:3244-3251.
27. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
28. Lee, K. L., H. R. Buckley, and C. C. Campbell. 1975. An amino acid liquid synthetic medium for the development of mycclial and yeast forms of Candida albicans. Sabouraudia 13:148-153.
29. Martin, G., D. Viskochil, G. Bollag, P. C. McCabe, W. J. Crosler, H. Haubruck, L. Conroy, R. Clark, P. O'Connell, R. M. Cawthon, M. A. Innis, and F. McCormick. 1990. The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21. Cell 63:843-849.
30. Matsudaira, P. 1987. Sequence from picomolc quantities of proteins electroblotted onto polyvinylidene difluoride membranes. J. Biol. Chem. 262: 10035-10038.
31. Mazur, P., and W. Baginsky. 1996. In vitro activity of 1,3-β-glucan synthase requires the GTP-binding protein Rho1. J. Biol. Chem. 271:14604-14609.
32. Mitchell, L. H., and D. R. Soll. 1979. Commitment to germ tube or bud formation during release from stationary phase in Candida albicans. Exp. Cell Res. 120:167-179.
33. Mol, P. C., H. Park, J. T. Mullins, and E. Cabib. 1994. A GTP-binding protein regulates the activity of (1,3)-β-glucan synthase, an enzyme directly involved in yeast cell wall morphogenesis. J. Biol. Chem. 269:31267-31274.
34. Oh, C., D. A. Toke, S. Mandala, and C. E. Martin. 1997. ELO2 and ELO3, homologues of the Saccharomyces cerevisiae ELO1 gene, function in fatty acid elongation and are required for sphingolipid formation. J. Biol. Chem. 272:17376-17384.
35. Pfaller, M., and R. Wenzel. 1992. Impact of the changing epidemiology of fungal infections in the 1990s. Eur. J. Clin. Microbiol. Infect. Dis. 11:287-291.
36. Pfaller, M. A. 1994. Epidemiology and control of fungal infections. Clin. Infect. Dis. 19(Suppl. 1):S8-S13.
37. Pfaller, M. A., S. A. Messer, and S. Coffman. 1997. In vitro susceptibilities of clinical yeast isolates to a new echinocandin derivative, LY3033566, and other antifungal agents. Antimicrob. Agents Chemother. 41:763-766.
38. Pittet, D., and R. P. Wenzel. 1995. Nosocomial bloodstream infections. Arch. Intern. Med. 155:1177-1184.
39. Raab, P., D. J. Zeckner, B. Boyll, C. Boylan, and W. Current. 1994. Presented at the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy, Orlando, Fla., 4 to 7 Oct. 1994.
40. Ram, A. F. J., S. S. C. Brekelmans, L. J. W. M. Oehlen, and F. M. Klis. 1995. Identification of two cell cycle regulated genes affecting the β1,3-glucan content of cell walls in Saccharomyces cerevisiae. FEBS Lett. 358:165-170.
41. Rex, J. H., M. G. Rinaldi, and M. A. Pfaller. 1995. Resistance of Candida species to fluconazole. Antimicrob. Agents Chemother. 39:1-8.
42. Sawistowska-Schroder, E. T., D. Kerridge, and H. Perry. 1984. Echinocandin inhibition of 1,3-beta-D-glucan synthase from Candida albicans. FEBS Lett. 173:134-138.
43. Shematek, E. M., and E. Cabib. 1980. Biosynthesis of the yeast cell wall. II. Regulation of β-(1,3)glucan synthetase by ATP and GTP. J. Biol. Chem. 255:895-902.
44. Sokolov, B. P., B. M. Sher, and V. N. Kalinin. 1989. Modified method for peptide mapping of collagen chains using cyanogen bromide-cleavage of protein within polyacrylamide gels. Anal. Biochem. 176:365-367.
45. Taft, C. S., and C. P. Selitrennikoff. 1990. Cilofungin inhibition of (1,3)-β-glucan synthase: the lipophilic side chain is essential for inhibition of enzyme activity. J. Antibiot. 43:433-437.
46. Taft, C. S., T. Stark, and C. P. Selitrennikoff. 1988. Cilofungin (LY121019) inhibits Candida albicans (1-3)-β-D-glucan synthase activity. Antimicrob. Agents Chemother. 32:1901-1903.
47. Tang, J., and T. R. Parr, Jr. 1991. W-1 solubilization and kinetics of inhibition by cilofungin of Candida albicans (1,3)-β-D-glucan synthase. Antimicrob. Agents Chemother. 35:99-103.
48. Vessels, J. M., and J. A. Radding. 1993. Oligosaccharide mapping of fungal glucan synthase product by high-performance anion-exchange chromatography. Anal. Biochem. 215:150-155.
49. Xu, G., P. O'Connell, D. Viskochil, R. Cawthon, M. Robertson, M. Culver, D. Dunn, J. Stevens, R. Gesteland, R. White, and R. Weiss. 1990. The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell 62: 599-608.